Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2008, Article ID 637517, 3 pages
Letter to the Editor

Large Intestine Histopathology of Pegylated-Interferon-Alpha Plus Ribavirin Treated Chronic Hepatitis C Patients

1Department of Internal Medicine and Hepatogastroenterology, Faculty of Nursing, Helena Venizelou Hospital, University of Athens, Athens 11521, Greece
2Department of Pathology, Hygeia Hospital, Athens 15123, Greece

Received 31 March 2007; Accepted 13 January 2008

Copyright © 2008 Konstantinos D. Pantazis et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. W. Fried, M. L. Shiffman, K. R. Reddy et al., “Peginterferon α-2a plus ribavirin for chronic hepatitis C virus infection,” New England Journal of Medicine, vol. 347, no. 13, pp. 975–982, 2002. View at Publisher · View at Google Scholar · View at PubMed
  2. M. Cottone, A. Magliocco, G. Trallori et al., “Clinical course of inflammatory bowel disease during treatment with interferon for associated chronic active hepatitis,” Italian Journal of Gastroenterology, vol. 27, no. 1, pp. 3–4, 1995. View at Google Scholar
  3. S. Bargiggia, D. Thorburn, A. Anderloni et al., “Is interferon-α therapy safe and effective for patients with chronic hepatitis C and inflammatory bowel disease? A case-control study,” Alimentary Pharmacology & Therapeutics, vol. 22, no. 3, pp. 209–215, 2005. View at Publisher · View at Google Scholar · View at PubMed
  4. H. Tilg, H. Vogelsang, O. Ludwiczek et al., “A randomised placebo controlled trial of pegylated interferon α in active ulcerative colitis,” Gut, vol. 52, no. 12, pp. 1728–1733, 2003. View at Publisher · View at Google Scholar
  5. Y. Yamamoto, N. Sakatani, S. Yano et al., “Interferon induced IBD-like acute colitis—two cases of patients with chronic active hepatitis,” Nippon Shokakibyo Gakkai Zasshi, vol. 92, no. 9, pp. 1293–1296, 1995. View at Google Scholar
  6. C. Mavrogiannis, I. S. Papanikolaou, I. S. Elefsiniotis, D. I. Psilopoulos, A. Karameris, and G. Karvountzis, “Ulcerative colitis associated with interferon treatment for chronic hepatitis C,” Journal of Hepatology, vol. 34, no. 6, pp. 964–965, 2001. View at Publisher · View at Google Scholar
  7. F. Villa, M. G. Rumi, C. Signorelli et al., “Onset of inflammatory bowel diseases during combined α-interferon and ribavirin therapy for chronic hepatitis C: report of two cases,” European Journal of Gastroenterology & Hepatology, vol. 17, no. 11, pp. 1243–1245, 2005. View at Publisher · View at Google Scholar
  8. R. Sprenger, M. Sagmeister, and F. Offner, “Acute ulcerative colitis during successful interferon/ribavirin treatment for chronic hepatitis,” Gut, vol. 54, no. 3, pp. 438–439, 2005. View at Google Scholar
  9. E. M. Porter, C. L. Bevins, D. Ghosh, and T. Ganz, “The multifaceted Paneth cell,” Cellular and Molecular Life Sciences, vol. 59, no. 1, pp. 156–170, 2002. View at Publisher · View at Google Scholar